Showing results (101-110 of 113) with videos related to
Sort By:
Pageof 12
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 21, 2010
Long-term efficacy and safety of Raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection: week 96 results of the BENCHMRK 1 and 2 Phase III trialsRoy T Steigbigel, David A Cooper, Hedy Teppler, et al.Plos One|January 30, 2010
Phase 1 safety and immunogenicity evaluation of ADVAX, a multigenic, DNA-based clade C/B' HIV-1 candidate vaccineSandhya Vasan, Sarah J Schlesinger, Yaoxing Huang, et al.Journal of Virology|April 13, 2012
Uncommon pathways of immune escape attenuate HIV-1 integrase replication capacityMark A Brockman, Denis R Chopera, Alex Olvera, et al.Plos Pathogens|May 21, 2010
High Multiplicity Infection by HIV-1 in Men Who Have Sex with MenHui Li, Katharine J Bar, Shuyi Wang, et al.Plos Medicine|July 8, 2009
Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infectionMarc C Levesque, M Anthony Moody, Kwan-Ki Hwang, et al.The New England Journal of Medicine|July 25, 2008
Raltegravir with optimized background therapy for resistant HIV-1 infectionRoy T Steigbigel, David A Cooper, Princy N Kumar, et al.The New England Journal of Medicine|July 25, 2008
Subgroup and resistance analyses of raltegravir for resistant HIV-1 infectionDavid A Cooper, Roy T Steigbigel, Jose M Gatell, et al.Plos Genetics|April 26, 2014
Genotypic and functional impact of HIV-1 adaptation to its host population during the North American epidemicLaura A Cotton, Xiaomei T Kuang, Anh Q Le, et al.Nature Reviews. Immunology|July 21, 2012
Towards an HIV cure: a global scientific strategy, Steven G Deeks, Brigitte Autran, et al.The Journal of Experimental Medicine|October 12, 2011
Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutatedHua-Xin Liao, Xi Chen, Supriya Munshaw, et al.Pageof 12